Radiofrequency Surgical Tool Ready for Market
The new MarketPEAK Surgery System, indicated for use during general surgical procedures, procured marketing clearance from the FDA. The tool is manufactured by PEAK Surgical.
The tool incorporates the PEAK PlasmaBlade 4.0 and the company’s PULSAR Generator. The PlasmaBlade component is a tool that supports surgical coagulation and cutting with a low temperature. The Generator delivers the system with pulsed plasma radiofrequency energy. Cutting can be completed in either a dry or wet surgical field.
Radiofrequency energy delivered by the system comes through short on-and-off pulses of the energy. The blade includes highly insulated electrodes, which lowers the temperature required to complete cutting. Decreased temperature reduces the amount of heat transferred during a procedure, as well as minimizing damage to tissue surrounding the surgical site.
The new system provides surgeons with one device that allows both control of bleeding and cutting precision. A benefit of the MarketPEAK compared to traditional tools for electrosurgery is diminished thermal damage to the surrounding tissue. It also negates the need to switch instruments to complete each of these tasks.
An additional benefit is the ability of the tool to perform standard cutting, as normally performed with a scalpel. The limitation with standard scapels is that they cannot simultaneously control bleeding that result during cutting.
Findings from trials with the new tool were presented at last year’s meeting of the American College of Surgeons. Data presented indicated the efficacy of the device in both controlling bleeding and cutting tissue, as well as equivalency with conventional tools available.
July 25, 2008 Related topics: Product Approval & Certification, Surgery